Clinical use of hirudin.

The pharmacokinetics and the effects on the haemostatic system of hirudin were assessed in healthy volunteers after single doses of 1,000 AT-U/kg administered intravenously respectively subcutaneously. First clinical experiences on hirudin treatment in chronic DIC are reported.